In a newborn of a mother with phenylketonuria (PKU), increased maternal phenylalanine concentrations are associated with which finding in the newborn?

Enhance your readiness for the MEDNAX Neonatal Nurse Practitioner Exam. Utilize flashcards, multiple-choice questions, and detailed explanations. Equip yourself for success!

Multiple Choice

In a newborn of a mother with phenylketonuria (PKU), increased maternal phenylalanine concentrations are associated with which finding in the newborn?

Explanation:
Elevated maternal phenylalanine during pregnancy is teratogenic to the fetal brain. Phenylalanine crosses the placenta, and when levels are high, it disrupts fetal brain development and growth, leading to reduced head circumference. In untreated maternal PKU, the newborn commonly shows microcephaly along with growth retardation and facial features. Ambiguous genitalia, hydrops fetalis, and macrocephaly are not typical findings of maternal PKU, making microcephaly the best description of the effect on the newborn.

Elevated maternal phenylalanine during pregnancy is teratogenic to the fetal brain. Phenylalanine crosses the placenta, and when levels are high, it disrupts fetal brain development and growth, leading to reduced head circumference. In untreated maternal PKU, the newborn commonly shows microcephaly along with growth retardation and facial features. Ambiguous genitalia, hydrops fetalis, and macrocephaly are not typical findings of maternal PKU, making microcephaly the best description of the effect on the newborn.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy